OS Therapies【OSTX】銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

1.8699

買値

売値

出来高

16,649

1.85 日の範囲 2.05

1.58 52 週間の範囲 4.90

前日終値

1.96

始値

1.95

時刻

100

1.86

最終取引時間

平均取引量 (3 か月)

32,487

財務取引量

US$ 31,910

VWAP

1.9167

Form 8-K - Current report

OS Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update

Topline Data from Phase 2b clinical trial of OST-HER2 in Osteosarcoma expected to be released in December 2024 OS Therapies, Inc. (NYSE-A: OSTX) (“OS Therapies” or “the Company”), a...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

OS Therapies to Present at The Spartan Capital Investor Conference

OS Therapies (NYSE-A: OSTX) (“OS Therapies” or “the Company”), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced that Paul Romness, Chief...

Form 8-K - Current report

Join OS Therapies’ Exclusive Live Investor Webinar and Q&A Session on October 30

OS Therapies (NYSE American: OSTX) (“OS Therapies” or “the Company”), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, is pleased to invite investors to...

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

OS Therapies Appoints Two Bio-Pharmaceutical Industry Veterans to the Board of Directors

Concurrently, the Company accepted the resignations of Dr. Colin Goddard and Mr. Joacim Borg OS Therapies (NYSE-A: OSTX) (“OS Therapies” or “the Company”), a clinical-stage immunotherapy and...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.0601	-3.11398963731	1.93	2.27	1.86	28319	2.08432222	CS
4	-0.9301	-33.2178571429	2.8	2.9443	1.58	28718	2.08759268	CS
12	-1.8501	-49.7338709677	3.72	3.765	1.58	32487	2.80533224	CS
26	-2.1301	-53.2525	4	4.9	1.58	123141	3.65642555	CS
52	-2.1301	-53.2525	4	4.9	1.58	123141	3.65642555	CS
156	-2.1301	-53.2525	4	4.9	1.58	123141	3.65642555	CS
260	-2.1301	-53.2525	4	4.9	1.58	123141	3.65642555	CS

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
UAMYUnited States Antimony Corp	US$ 1.35 (26.17%)	8.92M
CTMCastellum Inc	US$ 0.3451 (24.14%)	9.55M
KULRKULR Technology Group Inc	US$ 1.34 (17.54%)	27.23M
CIXCompX International Inc	US$ 32.47 (15.76%)	34.31k
SYNXSilynxcom Ltd	US$ 3.0725 (12.55%)	36.29k
SGNSigning Day Sports Inc	US$ 3.82 (-24.65%)	175.31k
STRWStrawberry Fields REIT Inc	US$ 9.5093 (-23.44%)	1.52M
QULLETRACS 2x Leveraged MSCI US Quality Factor TR ETN	US$ 42.43 (-20.00%)	1
LODEComstock Inc	US$ 0.408995 (-17.46%)	6.83M
MYNDMynd ai Inc	US$ 2.27 (-15.30%)	96.73k
MSTZT Rex 2X Inverse MSTR Daily Target ETF	US$ 0.9994 (8.63%)	994.92M
SOXLDirexion Daily Semiconductor Bull 3X Shares	US$ 29.12 (-5.70%)	59.28M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF	US$ 3.06 (0.00%)	45.85M
SPXSDirexion Daily S&P 500 Bear 3X Shares New	US$ 5.74 (0.53%)	36.58M
TZADirexion Daily Small Cap Bear 3X Share New	US$ 10.5962 (3.68%)	34.65M

JPetroInc 2月前

looking good Gerald...!

IMHO, you'll have this trading at $0.00028 in record time

here comes the Astoria Queens financial mafia wrecking crew to help assist you in your next financial debacle

so much for running TOMDF into insolvency and jumping ship to this firm which didn't last long:

Fortitude Advisors LLC

https://fortitudeadvisors.com/team/

"He is also the Chief Business Officer at OS Therapies, Inc. starting in 2024 and the Managing Partner at Fortitude Advisors LLC since 2019."

https://uk.marketscreener.com/insider/GERALD-COMMISSIONG-A19LFK/

I give Gerald Commissiong 6 months before OSTX fire's his arse - and for good measure...!

MOO pathetic

👍️0

JPetroInc 2月前

uh ho - Gerald Commissiong OSTX's new Chief Business Officer executive named...

and is the same old same old serial dilution 'scam artist' from AMBS & TOMDF

here we go again folks...!

buyers be ware - check these other 2 tickers for the catastrophic results by this Stanford Univ. Financial Engineering hack

https://ostherapies.com/leadership/

SMH - can't make this stuff up - sad but true...!

MOO tool

👍️0

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

OS Therapies Incorporated (OSTX)

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

OSTX 最新ニュース

Form 8-K - Current report

OS Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

OS Therapies to Present at The Spartan Capital Investor Conference

Form 8-K - Current report

Join OS Therapies’ Exclusive Live Investor Webinar and Q&A Session on October 30

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

OS Therapies Appoints Two Bio-Pharmaceutical Industry Veterans to the Board of Directors

Form 8-K - Current report

OS Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

OS Therapies to Present at The Spartan Capital Investor Conference

Form 8-K - Current report

Join OS Therapies’ Exclusive Live Investor Webinar and Q&A Session on October 30

Form 3 - Initial statement of beneficial ownership of securities

ムーバー

OSTX Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

OS Therapies Incorporated (OSTX) 銘柄情報

OS Therapies Incorporated (OSTX)

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

OSTX 最新ニュース

ムーバー

OSTX Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手